- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/06 - Antihyperlipidemics
Patent holdings for IPC class A61P 3/06
Total number of patents in this class: 4797
10-year publication summary
|
178
|
247
|
303
|
307
|
343
|
343
|
318
|
310
|
333
|
269
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Kowa Company, Ltd. | 1233 |
67 |
| Shionogi & Co., Ltd. | 884 |
47 |
| Daiichi Sankyo Company, Limited | 1890 |
44 |
| Amarin Pharmaceuticals Ireland Limited | 271 |
42 |
| Amgen Inc. | 4431 |
40 |
| Regeneron Pharmaceuticals, Inc. | 4741 |
39 |
| Takeda Pharmaceutical Company Limited | 2713 |
36 |
| Janssen Pharmaceutica N.V. | 3160 |
32 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 874 |
30 |
| Boehringer Ingelheim International GmbH | 4487 |
27 |
| Novartis AG | 10224 |
26 |
| Mochida Pharmaceutical Co., Ltd. | 340 |
26 |
| F. Hoffmann-La Roche AG | 7816 |
23 |
| AstraZeneca AB | 2820 |
23 |
| Albireo AB | 175 |
23 |
| Alnylam Pharmaceuticals, Inc. | 1181 |
23 |
| Eli Lilly and Company | 4106 |
23 |
| Sunshine Lake Pharma Co., Ltd. | 627 |
22 |
| The Regents of the University of California | 20790 |
21 |
| Suzhou Ribo Life Science Co., Ltd. | 144 |
20 |
| Other owners | 4163 |